Development of Complementary Photo‐arginine/lysine to Promote Discovery of Arg/Lys hPTMs Interactomes
Advanced Science · 2024
DOI: 10.1002/advs.202307526 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Yu Zong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, 10065, USA. Hauptthemen laut MEDLINE: Nucleosomes, Lysine. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Arginine and lysine, frequently appearing as a pair on histones, have been proven to carry diverse modifications and execute various epigenetic regulatory functions. However, the most context‐specific and transient effectors of these marks, while significant, have evaded study as detection methods have thus far not reached a standard to capture these ephemeral events. Herein, a pair of complementary photo‐arginine/δ‐photo‐lysine (R‐dz/K‐dz) probes is developed and involve these into histone peptide, nucleosome, and chromatin substrates to capture and explore the interactomes of Arg and Lys hPTMs. By means of these developed tools, this study identifies that H3R2me2a can recruit MutS protein homolog 6 (MSH6), otherwise repelDouble PHD fingers 2 (DPF2), Retinoblastoma binding protein 4/7 (RBBP4/7). And it is disclosed that H3R2me2a inhibits the chromatin remodeling activity of the cBAF complex by blocking the interaction between DPF2 (one component of cBAF) and the nucleosome. In addition, the novel pairs of H4K5 PTMs and respective readers are highlighted, namely H4K5me‐Lethal(3)malignant brain tumor‐like protein 2 (L3MBTL2), H4K5me2‐L3MBTL2, and H4K5acK8ac‐YEATS domain‐containing protein 4 (YEATS4). These powerful tools pave the way for future investigation of related epigenetic mechanisms including but not limited to hPTMs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, 10065, USA.
- Program of Pharmacology, Weill Cornell Medical College of Cornell University, New York, 10065, USA.
- Proteomics Resource Center, Rockefeller University, New York, 10065, USA.
- Structural Genomics Consortium, University of Toronto, Toronto, M5S3H2, Canada.
- Department of Molecular Biology, Princeton University, Princeton, 08544, USA.
ORCID-Profile: Yu Zong
Förderung
- NCI NIH HHS
Zitieren
APA
Zong, Y., Weiss, N., Wang, K., Pagano, A. E., Heissel, S., Perveen, S., & Huang, J. (2024). Development of Complementary Photo‐arginine/lysine to Promote Discovery of Arg/Lys hPTMs Interactomes. Advanced Science. https://doi.org/10.1002/advs.202307526
Vancouver
Zong Y, Weiss N, Wang K, Pagano AE, Heissel S, Perveen S, et al. Development of Complementary Photo‐arginine/lysine to Promote Discovery of Arg/Lys hPTMs Interactomes. Advanced Science. 2024. doi:10.1002/advs.202307526
BibTeX
@article{Zong2024,
author = {Zong, Yu and Weiss, Nicole and Wang, Ke and Pagano, Alexandra E and Heissel, Søren and Perveen, Sumera and Huang, Jian},
title = {Development of Complementary Photo‐arginine/lysine to Promote Discovery of Arg/Lys hPTMs Interactomes},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202307526}
}
EUVIMED